| Literature DB >> 33058758 |
H Ceren Ates1, Jason A Roberts2, Jeffrey Lipman3, Anthony E G Cass4, Gerald A Urban5, Can Dincer6.
Abstract
Recent technological advances have stimulated efforts to bring personalized medicine into practice. Yet, traditional application fields like therapeutic drug monitoring (TDM) have remained rather under-appreciated. Owing to clear dose-response relationships, TDM could improve patient outcomes and reduce healthcare costs. While chromatography-based routine practices are restricted due to high costs and turnaround times, biosensors overcome these limitations by offering on-site analysis. Nevertheless, sensor-based approaches have yet to break through for clinical TDM applications, due to the gap between scientific and clinical communities. We provide a critical overview of current TDM practices, followed by a TDM guideline to establish a common ground across disciplines. Finally, we discuss how the translation of sensor systems for TDM can be facilitated, by highlighting the challenges and opportunities.Entities:
Keywords: PK/PD models; biosensors; immunoassays; on-site drug monitoring; pharmacokinetics; wearables
Year: 2020 PMID: 33058758 DOI: 10.1016/j.tibtech.2020.03.001
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536